Canagliflozin, an SGLT-2 inhibitor, ameliorates acetic acid-induced colitis in rats through targeting glucose metabolism and inhibiting NOX2
Autor: | Morsy, Mohamed A., Khalaf, Hanaa M., Rifaai, Rehab A., Bayoumi, Asmaa M.A., Khalifa, Esraa M.M.A., Ibrahim, Yasmine F. |
---|---|
Zdroj: | In Biomedicine & Pharmacotherapy September 2021 141 |
Databáze: | ScienceDirect |
Externí odkaz: |